ICCC
ImmuCell Corporation - Common Stock (ICCC)
$95
About ImmuCell Corporation - Common Stock (ICCC)
ImmuCell Corp. engages in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. It operates through the following segments: Scours and Mastitis. The Scours segment consists of the First Defense product line. The Mastitis segment includes the CMT product line consisting of reagents and equipment used for rapid cow-side testing to identify mastitic quarters by detecting elevated somatic cell counts. The company was founded in 1982 and is headquartered in Portland, ME.
Details
Daily high
$9.99
Daily low
$9.68
Price at open
$9.80
52 Week High
$12.10
52 Week Low
$4.52
Market cap
90.4M
Dividend yield
-
Volume
10,036
Avg. volume
16,945
P/E ratio
118.59
ImmuCell Corporation - Common Stock News
Details
Daily high
$9.99
Daily low
$9.68
Price at open
$9.80
52 Week High
$12.10
52 Week Low
$4.52
Market cap
90.4M
Dividend yield
-
Volume
10,036
Avg. volume
16,945
P/E ratio
118.59